Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Long, Youming ^a   Zheng, Yangbo ^a   Chen, Mengyu ^a   Zhang, Bin ^a   Gao, Cong ^a   Shan, Fulan ^a   Yang, Ning ^a   Fan, Yongxiang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN; LIOTHYRONINE; METHYLPREDNISOLONE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; ANTI-THYROGLOBULIN; AUTOANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHINESE; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MEGADOSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HYPERTHYROIDISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SPINAL CORD LESION; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; BLOOD; CHILD; COHORT ANALYSIS; DEMYELINATING DISEASES; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; PATHOLOGY; SPINAL CORD; SPINAL CORD DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; COHORT STUDIES; DEMYELINATING DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; SPINAL CORD; SPINAL CORD DISEASES; THYROTROPIN; YOUNG ADULT;

EID: 84905460209     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100672     Document Type: Article

References (34)

1. Li R, Qiu W, Lu Z, Dai Y, Wu A, et al. (2011) Acute transverse myelitis in demyelinating diseases among the Chinese. J Neurol 258: 2206-2213.
2. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, et al. (2003) Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 9: 521-525. (Pubitemid 37287734)
3. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489. (Pubitemid 43958540)
4. Munteis E, Cano JF, Flores JA, Martinez-Rodriguez JE, Miret M, et al. (2007) Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort. Eur J Neurol 14: 1048-1052. (Pubitemid 47300781)
5. Sakuma R, Fujihara K, Sato N, Mochizuki H, Itoyama Y (1999) Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol 246: 449-453. (Pubitemid 29326838)
6. Karni A, Abramsky O (1999) Association of MS with thyroid disorders. Neurology 53: 883-885. (Pubitemid 29448322)
7. Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, et al. (2003) Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250: 672-675. (Pubitemid 36718353)
8. Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, et al. (1999) Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 162: 74-83. (Pubitemid 29064122)
9. Ramagopalan SV, Dyment DA, Valdar W, Herrera BM, Criscuoli M, et al. (2007) Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6: 604-610. (Pubitemid 46921044)
10. Qiu W, Bundell C, Wu JS, Castley A, James I, et al. (2010) Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult Scler 16: 351-354.
11. Marrie RA, Yu BN, Leung S, Elliott L, Warren S, et al. (2012) The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology 39: 135-142.
12. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, et al. (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65: 78-83.
13. Nagaishi A, Takagi M, Umemura A, Tanaka M, Kitagawa Y, et al. (2011) Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry 82: 1360-1364.
14. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, et al. (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131: 3072-3080.
15. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, et al. (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382-387. (Pubitemid 26118744)
16. Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W (2008) Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Semin Ophthalmol 23: 191-200. (Pubitemid 351574422)
17. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
18. (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59: 499-505.
19. Scott TF, Kassab SL, Pittock SJ (2006) Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 63: 1398-1400. (Pubitemid 44547550)
20. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815. (Pubitemid 47238676)
21. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
22. Long Y, Qiu W, Lu Z, Bao J, Wu A, et al. (2012) Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 19: 96-102.
23. Sellner J, Kalluri SR, Cepok S, Hemmer B, Berthele A (2011) Thyroid antibodies in aquaporin-4 antibody positive central nervous system autoimmunity and multiple sclerosis. Clin Endocrinol (Oxf) 75: 271-272.
24. Durelli L, Ferrero B, Oggero A, Verdun E, Bongioanni MR, et al. (1999) Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci 162: 74-83. (Pubitemid 29064122)
25. Caraccio N, Dardano A, Manfredonia F, Manca L, Pasquali L, et al. (2005) Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90: 4133-4137. (Pubitemid 41058187)
26. Cossburn M, Pace AA, Jones J, Ali R, Ingram G, et al. (2011) Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology 77: 573-579.
27. Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, et al. (2001) Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci 193: 17-22. (Pubitemid 33062390)
28. Brabant A, Brabant G, Schuermeyer T, Ranft U, Schmidt FW, et al. (1989) The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) 121: 95-100. (Pubitemid 19167537)
29. Torres SM, McKeever PJ, Johnston SD (1991) Effect of oral administration of prednisolone on thyroid function in dogs. Am J Vet Res 52: 416-421.
30. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, et al. (2008) CNS aquaporin-4 autoimmunity in children. Neurology 71: 93-100.
31. Niu D, Kondo T, Nakazawa T, Kawasaki T, Yamane T, et al. (2012) Differential expression of aquaporins and its diagnostic utility in thyroid cancer. PLOS ONE 7: e40770.
32. Stefaneanu L, Tasca C (1986) Immunohistochemical localization of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in thyroid diseases. Acta Histochem 78: 7-18. (Pubitemid 16157595)
33. Dawe K, Hutchings P, Champion B, Cooke A, Roitt I (1993) Autoantigens in thyroid diseases. Springer Semin Immunopathol 14: 285-307.
34. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, et al. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-187.